Rehana Wolfe

Rehana is a Director, Consulting Expert in CGI’s U.S operations’ life sciences sector. In this role, she helps clients assess and develop business strategies that deliver growth and prioritize strategic and technology solutions for go-to-market strategies. She has over 15 years of global biopharmaceutical experience spanning numerous geographies and therapeutic areas. Rehana is a global expert in vaccines commercialization in both public and private markets. Her functional expertise includes business strategy, organizational change management, portfolio prioritization and strategic partnerships. Her industry experience includes pharmaceutical, media, education and not-for-profit organizations.

From this author

Building your digital infrastructure from start-up to commercialization

February 4, 2022 Picture it - it’s been years since your vision of bringing a new therapy to market was set in motion. The team was small with an immediate focus on the product development stage. As the clock ticks away, the clinical trials have progressed, regulators are heavily engaged and you can see the ...

Digitizing the pharmaceutical and biotech value chain

September 13, 2021 I’ve been having a lively debate with a few of my colleagues about the digital value chain: a holistic view, of how technology enhances, connects and integrates the entire organization to deliver superior customer outcomes. We’ve been trying to pinpoint why so many digital transformation efforts ...

Lessons learned: How the rapid development of the COVID-19 vaccine could shape the future of pharma

June 8, 2021 It has been over a year since the COVID-19 pandemic began to upend economies, lives, and social interactions around the globe. Initially the promise of a vaccine seemed bleak at best – with such medications typically taking years, if not decades, to develop. However, the urgency for progress of a ...